Epigallocatechin-3-gallate inhibits collagen production of nasal polyp-derived fibroblasts

Phytotherapy Research

Volumn 28, Issue 1, 2014, Pages 98-103

  Kang, Jae Seong ^a   Park, Il Ho ^a   Cho, Jung Sun ^a   Hong, Sung Moon ^a   Kim, Tae Hoon ^a   Lee, Sang Hag ^a   Lee, Heung Man ^a,b  

^a Korea University College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

( ) epigallocatechin 3 gallate; extracellular matrix; nasal polyp derived fibroblast; TGF 1

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; COLLAGEN TYPE 1; EPIGALLOCATECHIN GALLATE; MESSENGER RNA; NITROBLUE TETRAZOLIUM; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; DRUG DETERMINATION; DRUG MECHANISM; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; MALE; MYOFIBROBLAST; NOSE POLYP; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; YOUNG ADULT;

(-)-EPIGALLOCATECHIN-3-GALLATE; EXTRACELLULAR MATRIX; NASAL POLYP-DERIVED FIBROBLAST; TGF-Β1;

ACTINS; ADULT; ANTIOXIDANTS; CATECHIN; CELL DIFFERENTIATION; CELLS, CULTURED; COLLAGEN TYPE I; EXTRACELLULAR MATRIX; FEMALE; FIBROBLASTS; HUMANS; MALE; MYOFIBROBLASTS; NASAL POLYPS; REACTIVE OXYGEN SPECIES; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84892438537     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4971     Document Type: Article

References (23)

1. Ahn HY, Kim CH, Ha TS,. 2010. Epigallocatechin-3-gallate Regulates NADPH Oxidase Expression in Human Umbilical Vein Endothelial Cells. Korean J Physiol Pharmacol 14: 325-329.
2. Blobe GC, Schiemann WP, Lodish HF,. 2000. Role of transforming growth factor beta in human disease. N Engl J Med 342: 1350-1358.
3. Cucoranu I, Clempus R, Dikalova A, et al,. 2005. NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ Res 97: 900-907.
4. Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G,. 1993. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 122: 103-111.
5. Gao YT, McLaughlin JK, Blot WJ, Ji BT, Dai Q, Fraumeni JF, Jr., 1994. Reduced risk of esophageal cancer associated with green tea consumption. J Natl Cancer Inst 86: 855-858.
6. Jung JW, Park IH, Cho JS, Lee HM,. 2013. Naringenin Inhibits Extracellular Matrix Production via Extracellular Signal-Regulated Kinase Pathways in Nasal Polyp-Derived Fibroblasts. Phytother Res 27: 463-467.
7. Kolb M, Bonniaud P, Galt T, et al,. 2002. Differences in the fibrogenic response after transfer of active transforming growth factor-beta1 gene to lungs of "fibrosis-prone" and "fibrosis-resistant" mouse strains. Am J Respir Cell Mol Biol 27: 141-150.
8. Koli K, Myllarniemi M, Keski-Oja J, Kinnula VL,. 2008. Transforming growth factor-beta activation in the lung: focus on fibrosis and reactive oxygen species. Antioxid Redox Signal 10: 333-342.
9. Larsen PL, Tos M, Kuijpers W, van der Beek JM,. 1992. The early stages of polyp formation. Laryngoscope 102: 670-677.
10. Lee SR, Im KJ, Suh SI, Jung JG,. 2003. Protective effect of green tea polyphenol (-)-epigallocatechin gallate and other antioxidants on lipid peroxidation in gerbil brain homogenates. Phytother Res 17: 206-209.
11. Lin SK, Shun CT, Kok SH, Wang CC, Hsiao TY, Liu CM,. 2008. Hypoxia-stimulated vascular endothelial growth factor production in human nasal polyp fibroblasts: effect of epigallocatechin-3-gallate on hypoxia-inducible factor-1 alpha synthesis. Arch Otolaryngol Head Neck Surg 134: 522-527.
12. Little SC, Early SB, Woodard CR, et al,. 2008. Dual action of TGF-beta1 on nasal-polyp derived fibroblasts. Laryngoscope 118: 320-324.
13. Moon YM, Park IH, Cho JS, Um JY, Kim TH, Lee HM,. 2013. Berberine Inhibits Myofibroblast Differentiation in Nasal Polyp-Derived Fibroblasts via the p38 Pathway. Phytother Res 27: 16-20.
14. Norlander T, Westrin KM, Fukami M, Stierna P, Carlsoo B,. 1996. Experimentally induced polyps in the sinus mucosa: a structural analysis of the initial stages. Laryngoscope 106: 196-203.
15. Park IH, Park SJ, Cho JS, et al,. 2012. Role of Reactive Oxygen Species in Transforming Growth Factor Beta1-Induced Alpha Smooth-Muscle Actin and Collagen Production in Nasal Polyp-Derived Fibroblasts. Int Arch Allergy Immunol 159: 278-286.
16. Pawankar R,. 2003. Nasal polyposis: an update: editorial review. Curr Opin Allergy Clin Immunol 3: 1-6.
17. Serpero L, Petecchia L, Sabatini F, et al,. 2006. The effect of transforming growth factor (TGF)-beta1 and (TGF)-beta2 on nasal polyp fibroblast activities involved upper airway remodeling: modulation by fluticasone propionate. Immunol Lett 105: 61-67.
18. da Silva EL, Abdalla DS, Terao J,. 2000. Inhibitory effect of flavonoids on low-density lipoprotein peroxidation catalyzed by mammalian 15-lipoxygenase. IUBMB Life 49: 289-295.
19. Tijburg LB, Wiseman SA, Meijer GW, Weststrate JA,. 1997. Effects of green tea, black tea and dietary lipophilic antioxidants on LDL oxidizability and atherosclerosis in hypercholesterolaemic rabbits. Atherosclerosis 135: 37-47.
20. Trevisanato SI, Kim YI,. 2000. Tea and health. Nutr Rev 58: 1-10.
21. Wang QP, Escudier E, Roudot-Thoraval F, Abd-Al Samad I, Peynegre R, Coste A,. 1997. Myofibroblast accumulation induced by transforming growth factor-beta is involved in the pathogenesis of nasal polyps. Laryngoscope 107: 926-931.
22. Yang CS, Wang ZY,. 1993. Tea and cancer. J Natl Cancer Inst 85: 1038-1049.
23. Zhang G, Miura Y, Yagasaki K,. 2000. Suppression of adhesion and invasion of hepatoma cells in culture by tea compounds through antioxidative activity. Cancer Lett 159: 169-173.